Spencer James Collis (Spencer J Collis, S J Collis)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

Cancers

British journal of cancer

Science advances

Expert reviews in molecular medicine

University of Sheffield

CRUK Paterson Institute for Cancer Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Sheffield

United Kingdom

Reader in Genome Stability :: Oncology and Metabolism

Education History

CRUK Paterson Institute for Cancer Research

United Kingdom

PHD

Publications

Aurelie Vanderlinden, Callum G Jones, Katie N Myers, Ola Rominiyi, Spencer James Collis
DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells. British journal of cancer (2023)
Hannah Gagg, Sophie T Williams, Samantha Conroy, Katie N Myers, Connor McGarrity-Cottrell, Callum Jones, Thomas Helleday, Juha Rantala, Ola Rominiyi, Sarah J Danson, Spencer James Collis, Greg Wells
Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients. F1000Research 12 (2023)
Sophie T Williams, Greg Wells, Samantha Conroy, Hannah Gagg, Richard Allen, Ola Rominiyi, Thomas Helleday, Katie Hullock, Catherine E W Pennington, Juha K Rantala, Spencer James Collis, Sarah J Danson
Precision oncology using ex vivo technology: a step towards individualised cancer care? Expert reviews in molecular medicine 24 (2022)
Ola Rominiyi, Spencer James Collis
DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies. Molecular oncology (2021)
Natasha Carmell, Ola Rominiyi, Katie N Myers, Connor McGarrity-Cottrell, Aurelie Vanderlinden, Nikita Lad, Eva Perroux-David, Sherif F El-Khamisy, Malee Fernando, Katherine G Finegan, Stephen Brown, Spencer James Collis
Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma. Cancers 13 (5) (2021)
L G Bennett, A M Wilkie, E Antonopoulou, I Ceppi, A Sanchez, Ellen Vernon, A Gamble, K N Myers, Spencer James Collis, P Cejka, C J Staples
MRNIP is a replication fork protection factor. Science advances 6 (28) (2020)
Ola Rominiyi, Aurelie Vanderlinden, Susan Jane Clenton, Caroline Bridgewater, Yahia Al-Tamimi, Spencer James Collis
Tumour treating fields therapy for glioblastoma: current advances and future directions. British journal of cancer 124 (4) (2020)
Ola Rominiyi, Yahia Al-Tamimi, Spencer James Collis
The 'Ins and Outs' of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong? Cancers 11 (3) (2019)

Spencer James Collis.css-eqlu8i{font-size:small;padding-left:4px;} (Spencer J Collis, S J Collis)

Publication Activity (10 Years)

Top Topics

Top Venues

Spencer James Collis (Spencer J Collis, S J Collis)